HYPD

NASDAQ · Pharmaceuticals

Hyperion Defi Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.27

-0.37 (-10.16%)

As of Mar 22, 10:51 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +393.6% upside

Low Target $9.68

Average Target $16.14

High Target $20.98

Current Price $3.27

Current
$3.27

Target
$16.14

$9.68 $16.14 avg $20.98

Scenario Analysis

Bear Case

$9.68

196.0%

Low target

Base Case

$16.14

+393.6%

Avg target

Bull Case

$20.98

+541.6%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$17.18

-81.0% from high

52-Week Low

$0.85

+284.7% from low

Target vs 52W High

$16.14

-6.1% vs high

Next Earnings Report

Apr 13, 2026 · After Market Close

17d

until earnings

EPS Est: $-4.71

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%